Dr. Birgit Kerber

Dr. Birgit Kerber

EMBLEM

Birgit Kerber has been actively engaged in establishing technology transfer at the European Molecular Biology Laboratory (EMBL) more than 20 years ago and over the years she has held various positions at EMBL Enterprise Management, EMBL’s technology transfer arm. Currently, Birgit is responsible for business development at the European Bioinformatics Institute, EMBL-EBI, including the Innovation and Translation programme and the public-private partnership Open Targets. She has managed and licensed EMBL intellectual property in a number of fields with biotech and large pharma companies as customers and is involved in starting companies out of EMBL. Birgit holds a diploma in biology from Philipps-University Marburg, did her PhD work in molecular developmental genetics at the Max-Planck-Institute for biophysical chemistry in Goettingen and a postdoc at EMBL Heidelberg. She is a member of BIO Deutschland and co-chair of the BIO Deutschland Technology Transfer working group as well as an alumna of St Gallen Business School, CEIPI, Boehringer Ingelheim Fonds, DFG and EMBO.